Matsuo K, Rocha FG, Ito K, D'Angelica MI, Allen PJ, Fong Y, Dematteo RP, Gonen M, Endo I, Jarnagin WR. The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg. 2012;215(3):343–55.
Article
PubMed
Google Scholar
Kaiser GM, Paul A, Sgourakis G, Molmenti EP, Dechêne A, Trarbach T, Stuschke M, Baba HA, Gerken G, Sotiropoulos GC. Novel prognostic scoring system after surgery for Klatskin tumor. Am Surg. 2013;79(1):90–5.
PubMed
Google Scholar
Farges O, Regimbeau JM, Fuks D, Le Treut YP, Cherqui D, Bachellier P, Mabrut JY, Adham M, Pruvot FR, Gigot JF. Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg. 2013;100(2):274–83.
Article
CAS
PubMed
Google Scholar
Wiggers JK, Koerkamp BG, Cieslak KP, Doussot A, van Klaveren D, Allen PJ, Besselink MG, Busch OR, D'Angelica MI, DeMatteo RP, et al. Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant. J Am Coll Surg. 2016;223(2):321–31.
Article
PubMed
Google Scholar
Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol. 2003;552(Pt 2):335–44.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology. 2003;125(4):1246–57.
Article
CAS
PubMed
Google Scholar
van Golen RF, van Gulik TM, Heger M. The sterile immune response during hepatic ischemia/reperfusion. Cytokine Growth Factor Rev. 2012;23(3):69–84.
Article
PubMed
Google Scholar
Kloek JJ, Maréchal X, Roelofsen J, Houtkooper RH, van Kuilenburg ABP, Kulik W, Bezemer R, Nevière R, van Gulik TM, Heger M. Cholestasis is associated with hepatic microvascular dysfunction and aberrant energy metabolism before and during ischemia-reperfusion. Antioxid Redox Signal. 2012;17(8):1109–23.
Article
CAS
PubMed
Google Scholar
Sokol RJ, Winklhofer-Roob BM, Devereaux MW, McKim JM. Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology. 1995;109(4):1249–56.
Article
CAS
PubMed
Google Scholar
Ljubuncic P, Fuhrman B, Oiknine J, Aviram M, Bomzon A. Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages. Gut. 1996;39(3):475–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vendemiale G, Grattagliano I, Lupo L, Memeo V, Altomare E. Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage. J Hepatol. 2002;37(5):601–5.
Article
CAS
PubMed
Google Scholar
Kanda H, Nimura Y, Yasui A, Uematsu T, Kamiya S, Machiki Y, Kitagawa Y, Shionoya S. Hepatic blood flow after acute biliary obstruction and drainage in conscious dogs. Hepatogastroenterology. 1996;43(7):235–40.
CAS
PubMed
Google Scholar
Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov. 2005;4(12):977–87.
Article
CAS
PubMed
Google Scholar
Awad AS, Kamel R. Effect of rosuvastatin on cholestasis-induced hepatic injury in rat livers. J Biochem Mol Toxicol. 2010;24(2):89–94.
CAS
PubMed
Google Scholar
Dold S, Laschke MW, Lavasani S, Menger MD, Jeppsson B, Thorlacius H. Simvastatin protects against cholestasis-induced liver injury. Br J Pharmacol. 2009;156(3):466–74.
Article
CAS
PubMed
PubMed Central
Google Scholar
Demirbilek S, Tas E, Gurunluoglu K, Akin M, Aksoy RT, Emre MH, Aydin NE, Ay S, Ozatay N. Fluvastatin reduced liver injury in rat model of extrahepatic cholestasis. Pediatr Surg Int. 2007;23(2):155–62.
Article
PubMed
Google Scholar
Kolouchova G, Brcakova E, Hirsova P, Sispera L, Tomsik P, Cermanova J, Hyspler R, Slanarova M, Fuksa L, Lotkova H, et al. Pravastatin modulates liver bile acid and cholesterol homeostasis in rats with chronic cholestasis. J Gastroenterol Hepatol. 2011;26(10):1544–51.
Article
CAS
PubMed
Google Scholar
Howe K, Sanat F, Thumser AE, Coleman T, Plant N. The statin class of HMG-CoA reductase inhibitors demonstrate differential activation of the nuclear receptors PXR, CAR and FXR, as well as their downstream target genes. Xenobiotica. 2011;41(7):519–29.
Article
CAS
PubMed
Google Scholar
Antoniades C, Bakogiannis C, Leeson P, Guzik TJ, Zhang M-H, Tousoulis D, Antonopoulos AS, Demosthenous M, Marinou K, Hale A, et al. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling. Circulation. 2011;124(3):335–45.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ajamieh H, Farrell G, Wong HJ, Yu J, Chu E, Chen J, Teoh N. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation. J Gastroenterol Hepatol. 2012;27(8):1353–61.
Article
CAS
PubMed
Google Scholar
Gracia-Sancho J, García-Calderó H, Hide D, Marrone G, Guixé-Muntet S, Peralta C, García-Pagán JC, Abraldes JG, Bosch J. Simvastatin maintains function and viability of steatotic rat livers procured for transplantation. J Hepatol. 2013;58(6):1140–6.
Article
CAS
PubMed
Google Scholar
Teoh NC, Ito Y, Field J, Bethea NW, Amr D, McCuskey MK, McCuskey RS, Farrell GC, Allison AC. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice. Gastroenterology. 2007;133(2):632–46.
Article
CAS
PubMed
Google Scholar
Ajamieh H, Farrell GC, McCuskey RS, Yu J, Chu E, Wong H-J, Lam W, Teoh NC. Acute atorvastatin is hepatoprotective against ischaemia-reperfusion injury in mice by modulating eNOS and microparticle formation. Liver Int. 2015;35(9):2174–86.
Article
CAS
PubMed
Google Scholar
Laufs U. Beyond lipid-lowering: effects of statins on endothelial nitric oxide. Eur J Clin Pharmacol. 2003;58(11):719–31.
Article
CAS
PubMed
Google Scholar
Peralta C, Jiménez-Castro MB, Gracia-Sancho J. Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J Hepatol. 2013;59(5):1094–106.
Article
PubMed
Google Scholar
Mencin A, Kluwe J, Schwabe RF. Toll-like receptors as targets in chronic liver diseases. Gut. 2009;58(5):704–20.
Article
CAS
PubMed
PubMed Central
Google Scholar
Llacuna L, Fernández A, Montfort CV, Matías N, Martínez L, Caballero F, Rimola A, Elena M, Morales A, Fernández-Checa JC, et al. Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury. J Hepatol. 2011;54(5):1002–10.
Article
CAS
PubMed
Google Scholar
Kocak FE, Kucuk A, Ozyigit F, Tosun M, Kocak C, Kocak A, Ekici MF, Yaylak F, Genc O. Protective effects of simvastatin administered in the experimental hepatic ischemia-reperfusion injury rat model. J Surg Res. 2015;199(2):393–401.
Article
CAS
PubMed
Google Scholar
Marsman HA, Heger M, Kloek JJ, Nienhuis SL, van Werven JR, Nederveen AJ, Ten Kate FJ, Stoker J, van Gulik TM. Reversal of hepatic steatosis by omega-3 fatty acids measured non-invasively by (1) H-magnetic resonance spectroscopy in a rat model. J Gastroenterol Hepatol. 2011;26(2):356–63.
Article
CAS
PubMed
Google Scholar
Krebs HA. The redox state of nicotinamide adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Adv Enzym Regul. 1967;5:409–34.
Article
CAS
Google Scholar
Marrone G, Russo L, Rosado E, Hide D, García-Cardeña G, García-Pagán JC, Bosch J, Gracia-Sancho J. The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins. J Hepatol. 2013;58(1):98–103.
Article
CAS
PubMed
Google Scholar
Stojakovic T, Claudel T, Putz-Bankuti C, Fauler G, Scharnagl H, Wagner M, Sourij H, Stauber RE, Winkler K, März W, et al. Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment. Atherosclerosis. 2010;209(1):178–83.
Article
CAS
PubMed
Google Scholar
Cámara-Lemarroy CR, la Garza FJ G-de, Alarcón-Galván G, Cordero-Pérez P, Muñoz-Espinosa L, Torres-González L, Fernández-Garza NE. Hepatic Ischemia/Reperfusion Injury Is Diminished by Atorvastatin in Wistar Rats. Arch Med Res. 2014;45(3):210–6.
Article
PubMed
Google Scholar
Koeppel TA, Trauner M, Baas JC, Thies JC, Schlosser SF, Post S, Gebhard MM, Herfarth C, Boyer JL, Otto G. Extrahepatic biliary obstruction impairs microvascular perfusion and increases leukocyte adhesion in rat liver. Hepatology. 1997;26(5):1085–91.
CAS
PubMed
Google Scholar
Thomas SR, Witting PK, Drummond GR. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal. 2008;10(10):1713–65.
Article
CAS
PubMed
Google Scholar
Yerushalmi B, Dahl R, Devereaux MW, Gumpricht E, Sokol RJ. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology. 2001;33(3):616–26.
Article
CAS
PubMed
Google Scholar
Olteanu D, Nagy A, Dudea M, Filip A, Muresan A, Catoi C, Mircea PA, Clichici S. Hepatic and systemic effects of rosuvastatin on an experimental model of bile duct ligation in rats. J Physiol Pharmacol. 2012;63(5):483–96.
CAS
PubMed
Google Scholar
Kurihara T, Akimoto M, Abe K, Ishiguro H, Niimi A, Maeda A, Shigemoto M, Yamashita K, Yokoyama I, Suzuki Y. Experimental use of pravastatin in patients with primary biliary cirrhosis associated with hypercholesterolemia. Clin Ther. 1993;15(5):890–8.
CAS
PubMed
Google Scholar
Ritzel U, Leonhardt U, Näther M, Schäfer G, Armstrong VW, Ramadori G. Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers. J Hepatol. 2002;36(4):454–8.
Article
CAS
PubMed
Google Scholar
Stanca CM, Bach N, Allina J, Bodian C, Bodenheimer H, Odin JA. Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis. Dig Dis Sci. 2008;53(7):1988–93.
Article
CAS
PubMed
Google Scholar
Stojakovic T, Putz-Bankuti C, Fauler G, Scharnagl H, Wagner M, Stadlbauer V, Gurakuqi G, Stauber RE, März W, Trauner M. Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid. Hepatology. 2007;46(3):776–84.
Article
CAS
PubMed
Google Scholar
Karsten TM, van Gulik TM, Spanjaard L, Bosma A, van der Bergh Weerman MA, Dingemans KP, Dankert J, Gouma DJ. Bacterial translocation from the biliary tract to blood and lymph in rats with obstructive jaundice. J Surg Res. 1998;74(2):125–30.
Article
CAS
PubMed
Google Scholar
Kloek JJ, Marsman HA, van Vliet AK, Gouma DJ, van Gulik TM. Biliary drainage attenuates postischemic reperfusion injury in the cholestatic rat liver. Surgery. 2008;144(1):22–31.
Article
CAS
PubMed
Google Scholar
Kloek JJ, Levi M, Heger M, van der Loos CM, Gouma DJ, van Gulik TM. Cholestasis enhances liver ischemia/reperfusion-induced coagulation activation in rats. Hepatol Res. 2010;40(2):204–15.
Article
CAS
PubMed
Google Scholar